COLLEGE STATION, Texas, March 29, 2019 /PRNewswire-PRWeb/ -- GenCure has selected G-CON Manufacturing, the leader in prefabricated, flexible cleanroom solutions, for its new multi-product cell therapy facility. The new facility, which will anchor the VelocityTX innovation center in San Antonio, Texas, will expand GenCure's manufacturing capabilities, providing new state of the art manufacturing capabilities to support clinical cell therapy trials. GenCure is a subsidiary of BioBridge Global, a family of non-profits, whose mission is to save and enhance lives through the healing power of human cells and tissue.
The PODs will provide approximately 6,700 sq. ft. of cleanroom space to facilitate production of the large numbers of consistent, high-quality, clinical-grade adult stem cells needed to help bring potential new therapies into human clinical trials. The site is designed to facilitate future expansion up to 14,000 sq. ft. of cleanroom capacity. Being prefabricated and largely autonomous, PODs are ideal for the planned expansion phases while avoiding impact to ongoing manufacturing.
"We are very excited and grateful for the opportunity to design and build PODs for this important project at GenCure," said Peter Makowenskyj, Director of Sales Engineering at G-CON Manufacturing. "Cell therapies can successfully treat previously unmet medical needs and for that reason are one of the fastest growing segments in our industry. Based on our experience in this space, G-CON is well prepared to support GenCure's needs by providing the fastest and most flexible technology available in the cleanroom market.
"There is a pent-up demand for stem cells needed to bring potential new cellular therapies into clinical trials, and the major bottleneck in the system is a lack of biomanufacturing capacity," said Becky Cap, Senior Vice President of BioBridge Global and Chief Operating Officer for GenCure. "An important benefit of G-CON's prefabricated modular cleanroom system is that it will speed up the design, build and validation process for our production facilities, supporting our goal of bringing the first phase of this new biomanufacturing space online by the end of the year."
About G-CON G-CON Manufacturing designs, produces and installs prefabricated cleanroom PODs®. G-CON's cleanroom POD portfolio encompasses a variety of different dimensions and purposes, from laboratory environments to personalized medicine and production process platforms. The POD cleanroom units are unique from traditional cleanroom structures due to the ease of scalability, mobility and the ability to repurpose the PODs once the production process reaches the end of its lifecycle. For more information, please visit the Company's website at http://www.gconbio.com.
About GenCure GenCure, a subsidiary of San Antonio-based nonprofit BioBridge Global, is focused on enabling the development of cell-based therapies by providing access to source materials, cGMP biomanufacturing experience and clinical research support. GenCure focuses on regenerative medicine through the Texas Cord Blood Bank, biomanufacturing facility, apheresis center and a deceased donor tissue bank. Learn more at http://www.gencure.org.
SOURCE G-CON Manufacturing
Advertisement
The PODs will provide approximately 6,700 sq. ft. of cleanroom space to facilitate production of the large numbers of consistent, high-quality, clinical-grade adult stem cells needed to help bring potential new therapies into human clinical trials. The site is designed to facilitate future expansion up to 14,000 sq. ft. of cleanroom capacity. Being prefabricated and largely autonomous, PODs are ideal for the planned expansion phases while avoiding impact to ongoing manufacturing.
Advertisement
"We are very excited and grateful for the opportunity to design and build PODs for this important project at GenCure," said Peter Makowenskyj, Director of Sales Engineering at G-CON Manufacturing. "Cell therapies can successfully treat previously unmet medical needs and for that reason are one of the fastest growing segments in our industry. Based on our experience in this space, G-CON is well prepared to support GenCure's needs by providing the fastest and most flexible technology available in the cleanroom market.
"There is a pent-up demand for stem cells needed to bring potential new cellular therapies into clinical trials, and the major bottleneck in the system is a lack of biomanufacturing capacity," said Becky Cap, Senior Vice President of BioBridge Global and Chief Operating Officer for GenCure. "An important benefit of G-CON's prefabricated modular cleanroom system is that it will speed up the design, build and validation process for our production facilities, supporting our goal of bringing the first phase of this new biomanufacturing space online by the end of the year."
About G-CON G-CON Manufacturing designs, produces and installs prefabricated cleanroom PODs®. G-CON's cleanroom POD portfolio encompasses a variety of different dimensions and purposes, from laboratory environments to personalized medicine and production process platforms. The POD cleanroom units are unique from traditional cleanroom structures due to the ease of scalability, mobility and the ability to repurpose the PODs once the production process reaches the end of its lifecycle. For more information, please visit the Company's website at http://www.gconbio.com.
About GenCure GenCure, a subsidiary of San Antonio-based nonprofit BioBridge Global, is focused on enabling the development of cell-based therapies by providing access to source materials, cGMP biomanufacturing experience and clinical research support. GenCure focuses on regenerative medicine through the Texas Cord Blood Bank, biomanufacturing facility, apheresis center and a deceased donor tissue bank. Learn more at http://www.gencure.org.
SOURCE G-CON Manufacturing
